An Overview of Research Advances in Oncology Regarding the Transcription Factor ATF4

被引：1

作者：

Chen, Yulu ^{[1
]}

Gao, Qi ^{[1
]}

Wang, Dan ^{[1
]}

Zou, Xun ^{[1
]}

Li, Xiuming ^{[1
]}

Ji, Jing ^{[1
]}

Liu, Bin ^{[1
]}

机构：

[1] Jiangsu Ocean Univ, Coll Pharm, Jiangsu Key Lab Marine Pharmaceut Cpd Screening, Lianyungang 222005, Peoples R China

来源：

CURRENT DRUG TARGETS | 2025年 / 26卷 / 01期

关键词：

ATF4; tumor; targeted therapy; transcription factor; malignant; ER stress; CANCER STATISTICS; GENE-EXPRESSION; STRESS; AUTOPHAGY; RESISTANCE; PATHWAY; RET; ANGIOGENESIS; DEGRADATION; FERROPTOSIS;

D O I：

10.2174/0113894501328461240921062056

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

This review provides a comprehensive overview of the recent advancements in research on ATF4 (Activating Transcription Factor 4) within the field of oncology. As a crucial transcription factor, ATF4 has garnered increasing attention for its role in cancer research. The review begins with an exploration of the regulatory mechanisms of ATF4, including its transcriptional control, post-translational modifications, and interactions with other transcription factors. It then highlights key research findings on ATF4's involvement in various aspects of tumor biology, such as cell proliferation, differentiation, apoptosis and survival, invasion and metastasis, and the tumor microenvironment. Furthermore, the review discusses the potential of targeting ATF4 as a novel therapeutic strategy for cancer treatment. It also explores how ATF4's interactions with existing anticancer drugs could inform the development of more effective therapeutic agents. By elucidating the role of ATF4 in tumor biology and its potential clinical applications, this review aims to provide new insights and strategies for cancer treatment.

引用

页码：59 / 72

页数：14

共 50 条

[1] The Transcription Factor ATF4 as a Neuroprotective Target in Parkinson Disease
Sun, Xiaotian
Greene, Lloyd A.
Levy, Oren A.
ANNALS OF NEUROLOGY, 2012, 72 : S138 - S138
[2] Acetylation of the transcription factor ATF4 influences its stability
Lassot, I
Emiliani, S
Benkirane, M
Benarous, R
MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 238A - 238A
[3] Activating transcription factor 4 (ATF4) in the porcine anterior pituitary
Kato, Y
Kato, T
Tomizawa, K
Ogawa, S
Koike, Y
ADVANCES IN COMPARATIVE ENDOCRINOLOGY, TOMES 1 AND 2, 1997, : 591 - 594
[4] GABAB receptors couple directly to the transcription factor ATF4
Vernon, E
Meyer, G
Pickard, L
Dev, K
Molnar, E
Collingridge, GL
Henley, JM
MOLECULAR AND CELLULAR NEUROSCIENCE, 2001, 17 (04) : 637 - 645
[5] Advances in the roles of ATF4 in osteoporosis
Xiao, Yaosheng
Xie, Xunlu
Chen, Zhixi
Yin, Guoqiang
Kong, Weihao
Zhou, Jianguo
BIOMEDICINE & PHARMACOTHERAPY, 2023, 169
[6] Presence of activating transcription factor 4 (ATF4) in the porcine anterior pituitary
Kato, Y
Koike, Y
Tomizawa, K
Ogawa, S
Hosaka, K
Tanaka, S
Kato, T
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 154 (1-2) : 151 - 159
[7] The Transcription Factor ATF4 Is an Essential Mediator of Skeletal Muscle Atrophy
Ebert, Scott Matthew
Kunkel, Steven D.
Dyle, Michael C.
Bullard, Steven A.
Adams, Christopher M.
FASEB JOURNAL, 2012, 26
[8] The Transcription Factor ATF4 Promotes Skeletal Myofiber Atrophy during Fasting
Ebert, Scott M.
Monteys, Alex Mas
Fox, Daniel K.
Bongers, Kale S.
Shields, Bridget E.
Malmberg, Sharon E.
Davidson, Beverly L.
Suneja, Manish
Adams, Christopher M.
MOLECULAR ENDOCRINOLOGY, 2010, 24 (04) : 790 - 799
[9] Transcriptional deregulation in Parkinson's disease by ATF4 transcription factor heterodimers
Jagannathan, Radhika
Roque, Claudio Gouveia
Hengst, Ulrich
NEUROLOGY, 2021, 96 (15)
[10] Functional Contribution of the Transcription Factor ATF4 to the Pathogenesis of Amyotrophic Lateral Sclerosis
Matus, Soledad
Lopez, Estefania
Valenzuela, Vicente
Nassif, Melissa
Hetz, Claudio
PLOS ONE, 2013, 8 (07):

← 1 2 3 4 5 →